Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Flolan 1.5mg powder and solvent for solution for infusion vials (GlaxoSmithKline UK Ltd) |
| BNF code | 0208010E0BBACAE |
| Virtual Medicinal Product | Epoprostenol 1.5mg powder and solvent for solution for infusion vials |
| Name | Flolan 1.5mg powder and solvent for solution for infusion vials |
| Abbreviated name | Flolan 1.5mg inf vials |
| Date of name applicability | 23 Jan 2025 |
| Previous name | Flolan 1.5mg powder and solvent (pH12) for solution for infusion vials |
| Supplier | GlaxoSmithKline UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Flolan 1.5mg powder and solvent for solution for infusion vials (GlaxoSmithKline UK Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_2.2.0_20250217000001, imported on 18th February 2025 at 03:53:40.